Proposed LCD DL40144: MolDX: Biomarker Testing for Risk Stratification in DCIS — Noridian
Oncology · LCD-DL40144
Government source· CMS / MACverify ↗Full analysis available with a CLV subscription.
View alertCPT procedure code
81281
Medicare payment
—
No national Medicare fee schedule we hold prices 81281. CMS fee schedules ↗
Code definition
Code
81281
Code system
CPT (Current Procedural Terminology)
This CPT code is not in our curated reference. CPT codes are maintained by the American Medical Association (AMA). Full descriptions require an AMA license.
Category
—
Short description sourced from CMS publicly available fee schedule data. Full CPT descriptions are copyright AMA. Not a substitute for the official CPT codebook.
Policy activity for CPT 81281
CLV Intelligence is tracking 1 policy change that cite CPT 81281 most recently on 2026-06-05, drawn from 1 proposed LCD. The changes span Oncology. 1 is flagged critical or high priority.
- proposed LCD
- 1
Counts reflect the source documents CLV has matched to CPT 81281 to date; each links to the government publication that is authoritative. Monitored daily from CMS, the Federal Register, and Medicare Administrative Contractor publications.
Policy changes matched to 81281
Matched to this code by CLV analysis of each policy. The linked source document is authoritative.
High
Audit documentation
Building an audit file that includes CPT 81281?
The Tripwire Audit Pack exports 12 months of single-specialty policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
See audit packs — $349One-time purchase · not a subscription
Get alerts when policy changes affect 81281
Free weekly digest — no subscription required.
Look up another code
Search ICD-10, HCPCS, or CPT codes with related reimbursement alerts.